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The aim of this study was to evaluate sensory aspects of airway protection in healthy 
ageing and in Parkinson’s disease (PD) using nasendoscopy and inhalation cough 
challenge. Forty-eight participants, gender equally represented, were divided into 3 
groups: Group 1- healthy, young adults, mean age 25.1; Group 2- healthy elders, 
mean age 72.8 and Group 3- patients with Idiopathic PD, mean age 71.7. All 
underwent sensory testing during nasendoscopy during which sensation was tested 
using the tip of the endoscope at bilateral base of tongue (BOT), posterior pharyngeal 
wall (PPW) and aryepiglittic fold (AEF). Inhalation cough challenge using citric acid 
was administered. There were no differences in sensitivity at BOT, PPW and AEF 
between young adults and elders. Patients with PD had significantly less sensation in 
the (R) and (L) BOT compared to healthy elders. In healthy young adults, elders and 
PD normal cough threshold was always significantly lower than the suppressed cough 
threshold (p=.001). There was no difference between young adults and elders for 
natural cough thresholds (p=.102), but a significant difference in suppressed cough 
thresholds (p=.021). Elders have a significantly lower suppressed cough threshold 
when compared to young adults. Natural and suppressed cough did not differ between 
healthy elders and those with PD. Young adults are better able to suppress cough 
compared to elders. This may suggesting reduced tolerance for noxious stimuli in 
elders and/or reduced cognitive control when asked to suppress cough. Reduced BOT 
sensation in patients may account for a delay in swallowing process, thereby 
increasing aspiration risk 
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Bioartificial Liver (BAL) is a term for medical devices designed to replace natural 
liver functions. The idea behind the use of artificial livers is to either externally 
support an injured liver to recovery or bridge a patient with a failing liver to 
transplantation. Our aim was to investigate the effect of microfluidic channel 
geometry on the modulation of oxygen transport to liver cells cultured in a 
Bioartificial Liver (BAL) bioreactor. Analytical calculations and finite-element 
simulations of fluid dynamics in microchannels were used to determine the influence 
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of wall-shear stress on oxygen transport in a microchannel containing a liver cells 
culture. To ensure hepatocyte survival over the full length of the bioreactor, an 
optimum channel shape for a constant oxygen concentration was calculated and a 
prototype bioreactor device was fabricated in Polydimethylsiloxane (PDMS) using 
soft lithography techniques. Fluid-dynamics simulation results regarding the effect of 
channel geometry on oxygen transport show good agreement with the analytical 
model able to predict channel geometry. Cell cultures in straight rectangular 
bioreactors are shown to be limited by high oxygen metabolism of hepatocytes. 
Through channel tapering wall-shear stress can be made to increase linearly within 
biological limits, while as a result oxygen concentration remains constant over the 
length of the bioreactor. Tapered bioreactors are fabricated in PDMS and bonded onto 
a glass substrate. Successful fluid flow and sealing is shown by application of a dye 
coloured liquid. A two layer design with 36 bioreactors demonstrates the feasibility of 
device scale-up towards a clinical size BAL. A geometrical approach to overcome 
transport constraints in micro-scale bioreactors has been introduced. Simulation 
results show that oxygen transport can be modified by customizing the shape of the 
reactor channel. Prototype bioreactors have been fabricated and tested. Selective cell 
seeding and the integration of a sensor to experimentally verify oxygen concentrations 
are currently being investigated.  
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Cardiovascular disease states are difficult to diagnose due to a variety of underlying 
dysfunctions combined with reflex mechanisms. To provide more consistent care a 
cardiovascular system model is combined with an efficient patient-specific parameter 
identification method. The goal is to identify the patient’s condition and to predict the 
future patient-specific reaction, making this approach a potential means for model-
based guided therapy. The model and parameter-identification method are validated 
using clinical haemodynamic data measured during drug induced porcine pulmonary 
embolism experiments (N=6) and PEEP titration experiments (N=6). Identified model 
parameters are correlated to create predictive measures of haemodynamic changes to 
clinical therapy or patient condition. Prediction is tested for observed changes in 
arterial pressure (AP), pulmonary arterial pressure (PAP) and stroke volume (SV) as 
caused by a clinical change in PEEP. The parameter-identification method tracked 
pulmonary embolism in porcine data from an initial healthy to the disease state. The 
full range of haemodynamic responses was captured with mean errors of 4.1% in the 
pressures and 3.1% in the volumes. Pulmonary resistance increased significantly with 
the onset of embolism, as expected, with the percentage increase ranging from 
89.98% to 261.44% of the initial state. Changes in AP, PAP and SV due to an 
increase in PEEP were predicted with a mean absolute percentage error less than 10% 
